Viemed Healthcare Earnings Estimate

VMD Stock  USD 7.57  0.14  1.82%   
The next projected EPS of Viemed Healthcare is estimated to be 0.0 with future projections ranging from a low of 0.0 to a high of 0.0. Viemed Healthcare's most recent 12-month trailing earnings per share (EPS TTM) is at 0.28. Please be aware that the consensus of earnings estimates for Viemed Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Viemed Healthcare is projected to generate 0.0 in earnings per share on the 31st of December 2025. Viemed Healthcare earnings estimates show analyst consensus about projected Viemed Healthcare EPS (Earning Per Share). It derives the highest and the lowest estimates based on Viemed Healthcare's historical volatility. Many public companies, such as Viemed Healthcare, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Viemed Healthcare Revenue Breakdown by Earning Segment

By analyzing Viemed Healthcare's earnings estimates, investors can diagnose different trends across Viemed Healthcare's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit Margin is expected to grow to 0.75, whereas Gross Profit is forecasted to decline to about 74 M.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.

Viemed Healthcare Earnings Estimation Breakdown

The calculation of Viemed Healthcare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Viemed Healthcare is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Viemed Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.1
0.00
Lowest
Expected EPS
0.0
0.00
Highest

Viemed Healthcare Earnings Projection Consensus

Suppose the current estimates of Viemed Healthcare's value are higher than the current market price of the Viemed Healthcare stock. In this case, investors may conclude that Viemed Healthcare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Viemed Healthcare's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
369.96%
0.1041
0.0
0.28

Viemed Healthcare Earnings History

Earnings estimate consensus by Viemed Healthcare analysts from Wall Street is used by the market to judge Viemed Healthcare's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Viemed Healthcare's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Viemed Healthcare Quarterly Gross Profit

36.14 Million

At present, Viemed Healthcare's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Net Income Applicable To Common Shares is expected to grow to about 11.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 39.3 M.
Hype
Prediction
LowEstimatedHigh
5.787.599.40
Details
Intrinsic
Valuation
LowRealHigh
6.998.8010.61
Details
Naive
Forecast
LowNextHigh
5.807.609.41
Details
3 Analysts
Consensus
LowTargetHigh
11.1612.2713.62
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Viemed assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Viemed Healthcare. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Viemed Healthcare's stock price in the short term.

Viemed Healthcare Earnings per Share Projection vs Actual

Actual Earning per Share of Viemed Healthcare refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Viemed Healthcare predict the company's earnings will be in the future. The higher the earnings per share of Viemed Healthcare, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Viemed Healthcare Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Viemed Healthcare, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Viemed Healthcare should always be considered in relation to other companies to make a more educated investment decision.

Viemed Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Viemed Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-03-04
2024-12-310.10.10410.0041
2024-11-06
2024-09-300.070.10.0342 
2024-08-07
2024-06-300.070.04-0.0342 
2024-05-06
2024-03-310.070.04-0.0342 
2024-03-06
2023-12-310.10.09-0.0110 
2023-11-01
2023-09-300.090.07-0.0222 
2023-08-09
2023-06-300.050.060.0120 
2023-05-08
2023-03-310.040.040.0
2023-03-02
2022-12-310.040.060.0250 
2022-11-01
2022-09-300.050.03-0.0240 
2022-08-02
2022-06-300.070.02-0.0571 
2022-05-03
2022-03-310.050.04-0.0120 
2022-03-07
2021-12-310.060.10.0466 
2021-11-01
2021-09-300.040.040.0
2021-08-02
2021-06-300.030.040.0133 
2021-05-03
2021-03-310.060.04-0.0233 
2021-03-03
2020-12-310.030.120.09300 
2020-11-04
2020-09-300.080.07-0.0112 
2020-08-04
2020-06-300.230.480.25108 
2020-05-04
2020-03-310.080.110.0337 
2020-03-03
2019-12-310.070.06-0.0114 
2019-11-04
2019-09-300.060.070.0116 
2019-08-09
2019-06-300.060.05-0.0116 
2019-05-06
2019-03-310.080.05-0.0337 
2019-02-27
2018-12-310.080.080.0
2018-11-05
2018-09-300.060.060.0

About Viemed Healthcare Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Viemed Healthcare earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Viemed Healthcare estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Viemed Healthcare fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings89.7 M53.6 M
Retained Earnings Total Equity80.3 M84.3 M
Earnings Yield 0.04  0.03 
Price Earnings Ratio 27.59  18.19 
Price Earnings To Growth Ratio 3.72  3.91 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.358
Earnings Share
0.28
Revenue Per Share
5.787
Quarterly Revenue Growth
0.196
Return On Assets
0.065
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.